Product NDC: | 59630-820 |
Proprietary Name: | Cedax |
Non Proprietary Name: | Ceftibuten dihydrate |
Active Ingredient(s): | 400 mg/1 & nbsp; Ceftibuten dihydrate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59630-820 |
Labeler Name: | Sciele Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050685 |
Marketing Category: | NDA |
Start Marketing Date: | 19951220 |
Package NDC: | 59630-820-20 |
Package Description: | 20 CAPSULE in 1 BOTTLE (59630-820-20) |
NDC Code | 59630-820-20 |
Proprietary Name | Cedax |
Package Description | 20 CAPSULE in 1 BOTTLE (59630-820-20) |
Product NDC | 59630-820 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ceftibuten dihydrate |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19951220 |
Marketing Category Name | NDA |
Labeler Name | Sciele Pharma, Inc. |
Substance Name | CEFTIBUTEN DIHYDRATE |
Strength Number | 400 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |